Literature DB >> 9893252

The RB family of cell cycle regulatory factors.

P Stiegler1, M Kasten, A Giordano.   

Abstract

The intense investigation of the retinoblastoma "tumor suppressor family" members, pRb, pRb2/p130, and p107, has revealed impressive mechanisms evolved to safeguard development and homeostasis in higher eukaryotes. Members of the retinoblastoma family are involved in implementing and controlling three major aspects of cellular life: (1) proliferative growth, (2) differentiation, and (3) apoptosis. The activities of these proteins are highly regulated, enabling them to precisely establish control. The pRb protein is well understood in its regulatory abilities and is considered a classical tumor suppressor. The role of pRb2/p130 protein in growth suppression and its potential as a tumor suppressor have been established during the last few years. The p107 protein, structurally and functionally similar to, but yet distinctive from, pRb2/p130, is characterized at a more rudimentary level. In this report, we review the latest data on the retinoblastoma protein family and its web of regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893252

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  10 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

3.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

5.  Lipin-1 expression is critical for keratinocyte differentiation.

Authors:  Minjung Chae; Ji-Yong Jung; Il-Hong Bae; Hyoung-June Kim; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2015-12-13       Impact factor: 5.922

Review 6.  Cell cycle kinases as therapeutic targets for cancer.

Authors:  Silvia Lapenna; Antonio Giordano
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

7.  RB2/p130 ectopic gene expression in neuroblastoma stem cells: evidence of cell-fate restriction and induction of differentiation.

Authors:  F P Jori; U Galderisi; E Piegari; G Peluso; M Cipollaro; A Cascino; A Giordano; M A Melone
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

8.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Authors:  Donato Tedesco; Jiri Lukas; Steven I Reed
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

9.  p300 alters keratinocyte cell growth and differentiation through regulation of p21(Waf1/CIP1).

Authors:  Ping-Pui Wong; Adam Pickard; Dennis J McCance
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

10.  Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA).

Authors:  Alcina F Nicol; Andréa Rodrigues Cordovil Pires; Simone R de Souza; Gerard J Nuovo; Beatriz Grinsztejn; Aparecida Tristão; Fabio B Russomano; Luciane Velasque; José R Lapa e Silva; Claude Pirmez
Journal:  BMC Cancer       Date:  2008-10-07       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.